United States · FDA National Drug Code directory
Aprepitant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-669_4e00638d-1cbc-f20f-e063-6294a90ac14c
- Product NDC
- 68001-669
- Form
- KIT
- Composition / generic term
- Aprepitant
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260203
- Source listing expiry
- 20271231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 DOSE PACK (68001-669-15) * 2 CAPSULE in 1 BLISTER PACK * 1 CAPSULE in 1 BLISTER PACK · 68001-669-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →